Matches in Nanopublications for { ?s ?p "[Sulfide is a powerful inhibitor of COX and short-chain fatty acid oxidation, with vasoactive and vasotoxic effects that explain the microangiopathy in ethylmalonic encephalopathy patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP425584.RAYxdo97r4CILHs2Kj3oc-Av6K-6saVxeEi15yavztN3A130_assertion description "[Sulfide is a powerful inhibitor of COX and short-chain fatty acid oxidation, with vasoactive and vasotoxic effects that explain the microangiopathy in ethylmalonic encephalopathy patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425584.RAYxdo97r4CILHs2Kj3oc-Av6K-6saVxeEi15yavztN3A130_provenance.
- NP476438.RAYEyLrMI2N49aHA2Yp4tR68RpcSuxBoPo1_ICtjLPwOQ130_assertion description "[Sulfide is a powerful inhibitor of COX and short-chain fatty acid oxidation, with vasoactive and vasotoxic effects that explain the microangiopathy in ethylmalonic encephalopathy patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476438.RAYEyLrMI2N49aHA2Yp4tR68RpcSuxBoPo1_ICtjLPwOQ130_provenance.
- NP541353.RAY8amTVAcQt1DqemmDbZRJQTfyh3GJbxniqmK0Apj50Y130_assertion description "[Sulfide is a powerful inhibitor of COX and short-chain fatty acid oxidation, with vasoactive and vasotoxic effects that explain the microangiopathy in ethylmalonic encephalopathy patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541353.RAY8amTVAcQt1DqemmDbZRJQTfyh3GJbxniqmK0Apj50Y130_provenance.
- NP225980.RAgb2iPcDdqzDbu9kk7uBeGKlDP36fRZ_zfWq_aMI2exM130_assertion description "[Sulfide is a powerful inhibitor of COX and short-chain fatty acid oxidation, with vasoactive and vasotoxic effects that explain the microangiopathy in ethylmalonic encephalopathy patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225980.RAgb2iPcDdqzDbu9kk7uBeGKlDP36fRZ_zfWq_aMI2exM130_provenance.
- NP466653.RA6GFoZLFTBC3_gfzEusm_CAO_Ztr19CWvcuj0YvqkWsI130_assertion description "[Sulfide is a powerful inhibitor of COX and short-chain fatty acid oxidation, with vasoactive and vasotoxic effects that explain the microangiopathy in ethylmalonic encephalopathy patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466653.RA6GFoZLFTBC3_gfzEusm_CAO_Ztr19CWvcuj0YvqkWsI130_provenance.
- NP618271.RAlCOS1V9FuODCDDAgOkaJd4nCU8W5G0jR7sfjfwD0Epw130_assertion description "[Sulfide is a powerful inhibitor of COX and short-chain fatty acid oxidation, with vasoactive and vasotoxic effects that explain the microangiopathy in ethylmalonic encephalopathy patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618271.RAlCOS1V9FuODCDDAgOkaJd4nCU8W5G0jR7sfjfwD0Epw130_provenance.